My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

82.69 -0.94 (-1.12%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings ↗

April 28, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 28, 2025

Via Benzinga

Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

April 28, 2025

Via Benzinga

Which stocks have an unusual volume on Monday? ↗

April 21, 2025

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

Via Chartmill

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

April 17, 2025

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Via Chartmill

These stocks have an unusual volume in today's session ↗

April 16, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Top stock movements in today's session. ↗

April 15, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Tuesday's session: top gainers and losers ↗

April 15, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 15, 2025

Via Benzinga

The market is filled with gapping stocks in Tuesday's session. ↗

April 15, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Via Chartmill

Crude Oil Moves Lower; Citigroup Posts Upbeat Results ↗

April 15, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

April 15, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Nasdaq Surges 100 Points; Bank of America Earnings Top Views ↗

April 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 31, 2025

Via Benzinga

Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder ↗

December 11, 2024

Spruce Biosciences discontinues tildacerfont trials for CAH as CAHmelia-204 misses primary endpoint and CAHptain-205 shows dose-dependent trends.

Via Benzinga

SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024 ↗

August 12, 2024

SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder ↗

June 04, 2024

Spruce Biosciences collaborates with HMNC Brain Health to advance tildacerfont, a precision therapeutic for major depressive disorder, using the Cortibon Genetic Selection Tool.

Via Benzinga

SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024 ↗

May 13, 2024

SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Pfizer Q1 Earnings and Revenues Beat Estimates ↗

May 01, 2024

PFE came out with quarterly earnings of $0.82 per share, beating the our eimate of $0.56 per share. This compares to earnings of $1.23 per share a year ago.

Via Talk Markets

Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall ↗

March 14, 2024

Spruce Biosciences faces setbacks as tildacerfont trials fail primary endpoints, raising concerns about drug efficacy and compliance. Analysts downgrade ratings and adjust price targets amid...

Via Benzinga

Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views ↗

March 14, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.35% to 38,905.20 while the NASDAQ fell 0.13% to 16,156.28....

Via Benzinga

Topics Stocks

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 14, 2024

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 14, 2024

Via Benzinga

Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings ↗

March 14, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.30% to 38,926.22 while the NASDAQ fell 0.44% to 16,107.04. The...

Via Benzinga

Topics Stocks

US Stocks Higher; Producer Prices Rise 0.6% In February ↗

March 14, 2024

U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.11% to 39,084.58 while the NASDAQ rose 0.30% to 16,226.13. The S&P...

Via Benzinga

Topics Stocks

Is Altria Giving Up on Anheuser-Busch (BUD) Stock? ↗

March 14, 2024

Anheuser-Busch stock is falling on Thursday following news that 10% holder Altria is selling a portion of its stake in BUD shares.

Via InvestorPlace

Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday? ↗

March 14, 2024

Spruce Biosciences' latest CAH studies: CAHmelia-203 & CAHptain-205. Discover insights on tildacerfont's efficacy, safety, and pharmacokinetics in adult & pediatric CAH patients.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 14, 2024

Via Benzinga

Why Is Fisker (FSR) Stock Down 41% Today? ↗

March 14, 2024

Fisker stock is falling hard on Thursday as FSR investors react to reports that the EV company is preparing to file for bankruptcy.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.